<DOC>
	<DOCNO>NCT01913119</DOCNO>
	<brief_summary>Extranodal NK/T-cell lymphoma rare disease entity aggressive clinical course poor prognosis . Currently , treatment option relapse refractory extranodal NK/T-cell lymphoma . Romidepsin histone deacetylase inhibitor approve cutaneous T-cell lymphoma . A recent phase II study romidepsin relapsed/refractory peripheral T-cell lymphoma report overall response rate 38 % ( 95 % confidence interval 24 % -53 % ) . The median duration overall response 8.9 month . Considering median number previous treatment patient three ( range 1-11 ) , romidepsin single agent activity relapsed/refractory T-cell lymphoma . Thus , single agent activity romidepsin demonstrate , could therapeutic agent combination salvage treatment .</brief_summary>
	<brief_title>A Pilot Study Romidepsin Relapsed Refractory Extranodal NK/T-cell Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Romidepsin</mesh_term>
	<criteria>1 . Patient belong one follow clinical situation 1 . Relapsed salvage chemotherapy 2 . Relapsed autologous stem cell transplantation 3 . Refractory salvage chemotherapy autologous stem cell transplantation 2 . Adequate organ function define follow criterion : 1 . Serum aspartate transaminase ( AST ; serum glutamic oxaloacetic transaminase ( SGOT ) ) serum alanine transaminase ( ALT ; serum glutamic pyruvic transaminase ( SGPT ) ) ≤2.5 x local laboratory upper limit normal ( ULN ) , AST ALT less equal 5 x ULN liver function abnormality due underlying malignancy 2 . Total serum bilirubin ≤ 1.5 x ULN 3 . Absolute neutrophil count ( ANC ) ≥1500/µL 4 . Platelets ≥ 75,000/µL 5 . Hemoglobin ≥ 9.0 g/dL ( may transfuse erythropoietin treat ) 6 . Serum calcium ≤ 12.0 mg/dL 7 . Serum creatinine ≤ 1.5 x ULN 3 . At least one measurable lesion 4 . ECOG PS 02 5 . Written inform consent 6 . Over 20 year 80 year age 1 . Previously receive allogeneic stem cell transplantation 2 . History know carcinomatous meningitis , evidence symptomatic leptomeningeal disease secondary CNS involvement CT MRI scan . 3 . Ongoing cardiac dysrhythmias NCI CTCAE grade ≥2 . 4 . Pregnancy breastfeed . 5 . Any Known cardiac abnormality 6 . HBV carrier 7 . Positive HIV</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>extranodal NKTcell lymphoma</keyword>
</DOC>